Beacon Investment Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3M | Sell |
77,031
-870
| -1% | -$387K | 1.51% | 18 |
|
|
2025
Q1 | $37.8M | Sell |
77,901
-923
| -1% | -$447K | 1.77% | 11 |
|
|
2024
Q4 | $31.7M | Sell |
78,824
-347
| -0.4% | -$140K | 1.38% | 21 |
|
|
2024
Q3 | $36.8M | Sell |
79,171
-61
| -0.1% | -$28.4K | 1.53% | 20 |
|
|
2024
Q2 | $37.1M | Buy |
79,232
+1,515
| +2% | +$710K | 1.59% | 20 |
|
|
2024
Q1 | $32.5M | Sell |
77,717
-203
| -0.3% | -$84.9K | 1.4% | 21 |
|
|
2023
Q4 | $31.7M | Buy |
77,920
+1,679
| +2% | +$683K | 1.44% | 22 |
|
|
2023
Q3 | $26.5M | Buy |
76,241
+1,968
| +3% | +$684K | 1.31% | 24 |
|
|
2023
Q2 | $26.1M | Buy |
74,273
+265
| +0.4% | +$93.3K | 1.2% | 25 |
|
|
2023
Q1 | $23.3M | Sell |
74,008
-832
| -1% | -$262K | 1.13% | 27 |
|
|
2022
Q4 | $21.6M | Buy |
74,840
+423
| +0.6% | +$122K | 1.11% | 26 |
|
|
2022
Q3 | $21.5M | Sell |
74,417
-455
| -0.6% | -$132K | 1.19% | 26 |
|
|
2022
Q2 | $21.1M | Buy |
74,872
+1,779
| +2% | +$501K | 1.1% | 27 |
|
|
2022
Q1 | $19.1M | Buy |
73,093
+42,536
| +139% | +$11.1M | 0.81% | 36 |
|
|
2021
Q4 | $6.71M | Sell |
30,557
-5,945
| -16% | -$1.31M | 0.26% | 80 |
|
|
2021
Q3 | $6.62M | Sell |
36,502
-398
| -1% | -$72.2K | 0.27% | 83 |
|
|
2021
Q2 | $7.44M | Sell |
36,900
-745
| -2% | -$150K | 0.3% | 76 |
|
|
2021
Q1 | $8.09M | Buy |
37,645
+202
| +0.5% | +$43.4K | 0.35% | 69 |
|
|
2020
Q4 | $8.85M | Sell |
37,443
-1,709
| -4% | -$404K | 0.41% | 64 |
|
|
2020
Q3 | $10.7M | Buy |
39,152
+709
| +2% | +$193K | 0.55% | 54 |
|
|
2020
Q2 | $11.2M | Buy |
38,443
+13,060
| +51% | +$3.79M | 0.64% | 48 |
|
|
2020
Q1 | $6.04M | Buy |
+25,383
| New | +$6.04M | 0.43% | 63 |
|